Evaluate Ltd.

https://www.evaluate.com

Since 1996, Evaluate, a Norstella company, has provided the life sciences industry with the data, insight and intelligence to facilitate confident decision making on high-value investments in treatments and markets. We enable our clients to embed our proprietary and industry data into their workflows, tools and processes so they can work more effectively and efficiently. About Norstella Norstella consists of several prominent pharmaceutical solutions providers—Citeline, Evaluate, MMIT, Panalgo, and The Dedham Group—united by a shared mission: to smooth the path to life-saving therapies for patients and providers. Norstella offers comprehensive insights throughout the drug development lifecycle, leveraging unparalleled data, cutting-edge technology, and expert insights and consultancy. *

	Start	2013-03-16 renamed
	Group	Norstella (MMIT / Managed Markets Insight & Technology) (Group)
	Predecessor	EvaluatePharma Ltd.
	Industry	pharma services
	Industry 2	information services
	Person	Kobewka, Deborah (Evaluate Ltd 201903– CEO before UK Dept for International Trade + IMS Health)
	Person 2	de Pass, Jonathan (Evaluate Ltd 201903 Chairman)

	Region	London, Greater London
	Country	United Kingdom (GB)
	Street	11–29 Fashion Street
	City	E1 6PX London
	Tel	+44-20-7377-0800
		Address record changed: 2024-03-19

Basic data	Employees	n. a.

		* Document for »About Section«: Inpart SAS. (2/29/24). "Press Release: Inpart and Evaluate Announce Strategic Partnership to Optimize Biopharma Dealmaking". Lyon.

		Record changed: 2024-03-19